组织凝血酶原激活剂,tissue plasminogen activator
1)tissue plasminogen activator组织凝血酶原激活剂
1.Injection oftissue plasminogen activator into the optic nerve in an animal model of retinal vein occlusion视盘内注射组织凝血酶原激活剂治疗视网膜中央静脉阻塞的初步研究(英文)
英文短句/例句
1.Electrophysiological evaluation of the safety of injection of tissue plasminogen activator into optic nerve in rabbits视盘内注射组织凝血酶原激活剂安全性的电生理学评价(英文)
2.Injection of tissue plasminogen activator into the optic nerve in an animal model of retinal vein occlusion视盘内注射组织凝血酶原激活剂治疗视网膜中央静脉阻塞的初步研究(英文)
3.tissue thromboplasti组织促凝血酶原激酶
4.The Recombinant Human Tissue-type Plasminogen Activator in the Treatment of Deep Venous Thrombosis of the Lower Extremities重组组织型纤溶酶原激活剂治疗下肢深静脉血栓形成的临床应用
parison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
6.The Influence of Different Thromboplastins Upon the International Normalised ratio (INR) and the Prothrombin Time Ratio (PTR)组织凝血活酶对凝血酶原时间比率与国际正常化比率的影响
7.DETERMINATION OF THE PLASMINOGEN ACTIVATOR IN THE TONSIL OF CHRONIC TONSILLITIS慢性扁桃体炎组织中的纤溶酶原激活剂测定
8.Clinical Study of the Expression of Tissue Factor and Urokinase Plasminogen Activator Receptor in Breast Cancer组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达
9.The Study on the Effect of Tissue-type Plasminogen Activator and Its Inhibitor-1 on the Formation of Pulmonary Thromboembolism;组织型纤溶酶原激活物及其抑制剂-1对肺血栓栓塞症形成影响的探讨
10.Role of Tissue-Type Plasminogen Activator in Neonatal Rat with Hypoxia-Ischemia Brain Damage组织纤维蛋白溶酶原激活剂在新生大鼠缺氧缺血性脑损伤中的作用
11.Experimental study on prevention of the peritoneal adhesion by recombinant tissue-type plasminogen activator on rats重组组织型纤溶酶原激活剂预防大鼠腹腔粘连的实验研究
12.Evaluation of the therapeutic effect of thrombolytic therapy with rt-PA and nursing intervention in patients with acute myocardial infarction急性心肌梗死重组组织型纤溶酶原激活剂溶栓治疗的观察及护理
13.Therapeutic effect observation of thrombolysis with rt-PA intravenous in recurrent cerebral infarction重组组织型纤溶酶原激活剂对再发性脑梗死静脉溶栓治疗评价
14.Therapeutic Effect of Ultra Earlier Thrombolysis of Recombinant Tissue Plasminogen Activator in Acute Cerebral Infarction重组组织型纤溶酶原激活剂超早期溶栓治疗急性脑梗死的疗效
15.Thrombolytic therapy with intravenous recombinant tissue plasminogen activator for acute cerebral infarction重组组织型纤溶酶原激活剂静脉溶栓治疗急性脑梗死19例
16.Therapeutic effect evaluation of recombinant tissue plasminogen activator in hyper acute cerebral infarction重组组织型纤溶酶原激活剂治疗急性脑梗死的疗效评价
17.thromboplastin antecedent促凝血酶原激酶先质
18.Study on Recombinant Nonglycosylated Urokinase-type Plasminogen Activator;重组非糖基化尿激酶型纤溶酶原激活剂的研究
相关短句/例句
tissue thromboplastin组织促凝血酶原激酶
3)tissue-type plasminogen activator组织型纤溶酶原激活剂
1.Expression of humantissue-type plasminogen activator in cow mammary gland;人组织型纤溶酶原激活剂牛乳腺生物反应器的研究
2.Studies on thrombolysis of recombinant humantissue-type plasminogen activator(rht-PA)and its mutants;重组人组织型纤溶酶原激活剂及其突变体的溶血栓研究
3.Trichoderma reesei 306 was a recombinant strain that can producetissue-type plasminogen activator(t-PA).里氏木霉(Trichoderma reesei)306是能够生物合成组织型纤溶酶原激活剂(t-PA)的基因工程菌株。
4)tPA组织型纤溶酶原激活剂
1.Expression oftPAcDNA Gene in BHK 21 Cell;组织型纤溶酶原激活剂cDNA在BHK21细胞中的表达
2.The Expression oftPA Directed by the Bovine BLG Regulatory Elements in the Mammary Gland of Transgenic Mice;牛β-乳球蛋白基因调控序列指导组织型纤溶酶原激活剂在小鼠乳腺中的表达
3.From the point of view of large-scale and rapid purification oftPA, a variety of methods for the purification oftPA and the separation of single-chain and two-chaintPA were reviewed.简述了用于大规模生产组织型纤溶酶原激活剂(tPA)的重组动物细胞及其培养工艺。
5)tissue plasminogen activator组织型纤溶酶原激活剂
1.Construction oftissue plasminogen activator eukaryotic expression vector and its expression in MCF-7 cell line;组织型纤溶酶原激活剂真核表达载体的构建及其在乳癌细胞系MCF-7中的瞬时表达
2.Construction of humantissue plasminogen activator minigene;人组织型纤溶酶原激活剂突变体微小基因的构建
3.Changes and its clinical significance of serum brain-derived neurotrophic factor level and plasmatissue plasminogen activator level in patients with amnestic mild cognitive impairment;遗忘型轻度认知功能损害患者血清脑源性神经营养因子及血浆组织型纤溶酶原激活剂水平变化及其临床意义
6)tissue-type plasminogen activator组织纤溶酶原激活剂
1.Erythrina trypsin inhibitor (ETI) is a natural serine protease inhibitor, with high inhibitive activity to trypsin, chemotrypsin andtissue-type plasminogen activator (t-PA).刺桐胰蛋白酶抑制剂(ETI)是一种丝氨酸蛋白酶抑制剂,可抑制胰蛋白酶、胰凝乳蛋白酶及组织纤溶酶原激活剂(t-PA)等。
延伸阅读
组织分子式：CAS号：性质：通常由结构和功能相似的细胞和细胞间物质组成的、具有一定结构的聚集体。
